Apocynum venetum L. leaves extract inhibits ferroptosis and improves renal fibrosis in diabetic kidney disease by regulating the Nrf2/HO-1 pathway
Frontiers in Pharmacology · 07.05.2026 · 17
DOI: 10.3389/fphar.2026.1807373 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 07.05.2026. Verfasst von Guohua Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Xinjiang Medical University, Urumqi, China. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Diabetic kidney disease (DKD) is a common microvascular complication of diabetes. Current treatments for DKD are limited and associated with side effects. Apocynum venetum L. leaves, a traditional herbal medicine, have pharmacological potential for DKD but their mechanisms of action remain unclear.
Purpose
Investigating the Pharmacological Effects and Mechanisms of Apocynum venetum L. leaves against DKD.
Methods
Using db/db mice as an in vivo model, Apocynum venetum L. leaves extract (AVLE) was administered via oral gavage for 12 weeks. Serum and urine parameters related to renal function were measured, and renal tissue histopathology staining was performed. In vitro , human renal tubular epithelial cells (HK-2) stimulated with high glucose (HG) were used to evaluate fibrosis-related protein expression and the pharmacological effects of AVLE. UHPLC-OE-MS was used to analyze the metabolites absorbed into serum after AVLE administration, proteomic analysis was employed to explore the potential mechanisms, and the key signaling pathways and protein expression levels were verified in vitro and in vivo . Proteomic analysis suggested that ferroptosis may be a key pathway, and HO-1 may be a potential target.
Results
Treatment with AVLE significantly reduced proteinuria, renal pathological damage, and fibrosis in db/db mice and mitigated HG-induced injury in HK-2 cells. A total of 60 metabolites absorbed into the serum of AVLE were identified. Proteomic analysis suggests that ferroptosis may be a key pathway, and HO-1 may be a potential target. Subsequent experimental verification showed that AVLE inhibited ferroptosis and regulated the Nrf2/HO-1 signaling pathway.
Conclusion
AVLE can improve diabetic kidney disease and is closely associated with the regulation of the Nrf2/HO-1 signaling pathway, thereby alleviating renal dysfunction, fibrosis, and oxidative stress. This study provides experimental evidence for the potential application of AVLE in the prevention and treatment of diabetic kidney disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, Xinjiang Medical University, Urumqi, China.
- State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization and The Key Laboratory of Plant Resources and Chemistry of Arid Zone, Xinjiang Technical Institute of Physics and Chemistry, Chines…
- Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology, Xinjiang Key Laboratory of Biopharmaceuticals and…
Zitieren
APA
Shi, G., Abuduaini, S., Chen, L., Erreken, S., Long, M., Tang, X., & Kang, J. (2026). Apocynum venetum L. leaves extract inhibits ferroptosis and improves renal fibrosis in diabetic kidney disease by regulating the Nrf2/HO-1 pathway. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1807373
Vancouver
Shi G, Abuduaini S, Chen L, Erreken S, Long M, Tang X, et al. Apocynum venetum L. leaves extract inhibits ferroptosis and improves renal fibrosis in diabetic kidney disease by regulating the Nrf2/HO-1 pathway. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1807373
BibTeX
@article{Shi2026,
author = {Shi, Guohua and Abuduaini, Subinuer and Chen, Li and Erreken, Subinuer and Long, Mei and Tang, Xiaoqian and Kang, Jinsen},
title = {Apocynum venetum L. leaves extract inhibits ferroptosis and improves renal fibrosis in diabetic kidney disease by regulating the Nrf2/HO-1 pathway},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1807373}
}
EUVIMED